Cerebral venous thrombosis (CVT) is an unusual form of stroke. It is little researched largely because it accounts for less than 1% of all strokes. The study will provide a much better understanding for the reasons underlying CVT, which is an unusual but very important cause of stroke in young (mainly female) adults. It could lead to a better prediction of who will have a CVT, as well as to discovery of specific treatments.
Disease of the chest portion of the largest artery in the body (the aorta), is known as thoracic aortic disease (TAD). The number of people experiencing TAD is increasing. This study is investigating how to make thoracic endovascular aortic stenting (TEVAR), the preferred method of treating TAD, safer by using extra protection devices.
Beyond impaired language function, people with aphasia report a range of psychosocial health problems which negatively affect their wellbeing, including reduced confidence and social isolation. These psychosocial problems are not adequately addressed by healthcare services. This study will pilot a new group-based singing intervention for improving the psychosocial health of people with aphasia.
As well as reducing independence, walking problems after stroke lead to lower daily activity, increasing risk of further stroke and health problems. A promising method of improving walking after stroke is through ‘auditory rhythmical cueing.’ which involves people walking to the rhythm of a sound beat. This method improves walking after stroke in the hospital, but has not been tested later on at home where recovery could continue.
About one third of stroke survivors acquire aphasia. This is a language disorder that disrupts the production and comprehension of speech, as well as reading and writing. This study will investigate whether a support group intervention can be delivered remotely to people with aphasia through a virtual island platform called Eva Park.
No two strokes are alike - the damage from each stroke leaves its own unique signature on a person's brain and behaviour. The current project will investigate how different types of stroke affect a person's long term recovery or deterioration
This study will explore whether an existing therapy, Solution Focused Brief Therapy (SFBT), can be used for people with aphasia. Information will also be collected to design a future large-scale trial evaluating this approach.
This study will investigate how other illnesses can affect stroke treatment and outcome. It will involve the analysis of electronic, linked datasets of health information from stroke patients in Scotland.
The aim of this study is to develop a fatigue management programme to improve stroke survivors' knowledge of post stroke fatigue (PSF) and to identify ways of managing it.
CADASIL is one of the most common genetic causes of stroke and dementia. Currently there is no treatment for CADASIL. In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. From these stem cells, smooth muscle cells (SMCs) will be generated in a tissue culture dish in the lab. This work may pave the way for new treatments for CADASIL, and will allow us to better understand the ways that gene mutation causes disease.